InspireMD Inc Share Price Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
06/03 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
06/03 | Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M | MT |
Sales 2024 * | 7.09M 592M | Sales 2025 * | 14.65M 1.22B | Capitalization | 45.76M 3.82B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 6.45 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.81% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01/20/01 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 31/11/31 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 76 | 13/20/13 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01/20/01 |
Thomas Kester
BRD | Director/Board Member | 77 | 06/16/06 |
1st Jan change | Capi. | |
---|---|---|
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.52B | |
+1.43% | 50.06B | |
+11.60% | 45.67B | |
+3.40% | 41B | |
+3.03% | 26.73B | |
+3.21% | 26.47B | |
+15.23% | 25.05B |